Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2007 3
2008 2
2009 2
2010 5
2011 5
2012 2
2013 4
2014 10
2015 2
2016 8
2017 10
2018 9
2019 15
2020 9
2021 10
2022 11
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Melanoma clonal heterogeneity leads to secondary resistance after adoptive cell therapy with tumor-infiltrating lymphocytes.
König D, Sandholzer M, Uzun S, Zingg A, Ritschard R, Thut H, Glatz K, Kappos EA, Schaefer DJ, Kettelhack C, Passweg JR, Holbro A, Baur K, Medinger M, Buser A, Lardinois D, Jeker LT, Khanna N, Stenner F, Kasenda B, Homicsko K, Matter M, Rodrigues Mantuano N, Zippelius A, Läubli H. König D, et al. Among authors: medinger m. Cancer Immunol Res. 2024 Apr 17. doi: 10.1158/2326-6066.CIR-23-0757. Online ahead of print. Cancer Immunol Res. 2024. PMID: 38631025
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan.
Seydoux C, Uppugunduri CRS, Medinger M, Nava T, Halter J, Heim D, Chalandon Y, Schanz U, Nair G, Cantoni N, Passweg JR, Ansari M. Seydoux C, et al. Among authors: medinger m. Bone Marrow Transplant. 2024 Feb;59(2):294. doi: 10.1038/s41409-023-02166-2. Bone Marrow Transplant. 2024. PMID: 38129515 Free PMC article. No abstract available.
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT.
Ben Hassine K, Seydoux C, Khier S, Daali Y, Medinger M, Halter J, Heim D, Chalandon Y, Schanz U, Nair G, Cantoni N, Passweg JR, Satyanarayana Uppugunduri CR, Ansari M. Ben Hassine K, et al. Among authors: medinger m. Transplant Cell Ther. 2024 Mar;30(3):332.e1-332.e15. doi: 10.1016/j.jtct.2023.12.003. Epub 2023 Dec 9. Transplant Cell Ther. 2024. PMID: 38081414 Free article.
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study.
Ragozzino S, Mueller NJ, Neofytos D, Passweg J, Müller A, Medinger M, Van Delden C, Masouridi-Levrat S, Chalandon Y, Tschudin-Sutter S, Khanna N; Swiss Transplant Cohort Study. Ragozzino S, et al. Among authors: medinger m. Bone Marrow Transplant. 2024 Feb;59(2):278-281. doi: 10.1038/s41409-023-02157-3. Epub 2023 Nov 30. Bone Marrow Transplant. 2024. PMID: 38036657 Free PMC article. No abstract available.
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan.
Seydoux C, Uppugunduri CRS, Medinger M, Nava T, Halter J, Heim D, Chalandon Y, Schanz U, Nair G, Cantoni N, Passweg JR, Ansari M. Seydoux C, et al. Among authors: medinger m. Bone Marrow Transplant. 2023 Jul;58(7):811-816. doi: 10.1038/s41409-023-01963-z. Epub 2023 Apr 21. Bone Marrow Transplant. 2023. PMID: 37085674 Free PMC article.
Allogeneic hematopoietic stem cell transplantation in non-Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better.
Rebmann E, Nabergoj M, Grandjean B, Stakia P, Stern A, Medinger M, Masouridi-Levrat S, Dantin C, Schanz U, Baldomero H, Passweg J, Nair G, Rovo A, Chalandon Y. Rebmann E, et al. Among authors: medinger m. EJHaem. 2022 Nov 13;4(1):258-261. doi: 10.1002/jha2.614. eCollection 2023 Feb. EJHaem. 2022. PMID: 36819159 Free PMC article.
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma.
Bohler J, Bacher U, Banz Y, Stadelmann R, Medinger M, Zander T, Pabst T. Bohler J, et al. Among authors: medinger m. Cancers (Basel). 2022 Dec 21;15(1):44. doi: 10.3390/cancers15010044. Cancers (Basel). 2022. PMID: 36612039 Free PMC article.
Dasatinib for treatment of CAR T-cell therapy-related complications.
Baur K, Heim D, Beerlage A, Poerings AS, Kopp B, Medinger M, Dirks JC, Passweg JR, Holbro A. Baur K, et al. Among authors: medinger m. J Immunother Cancer. 2022 Dec;10(12):e005956. doi: 10.1136/jitc-2022-005956. J Immunother Cancer. 2022. PMID: 36455991 Free PMC article.
101 results